Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

2,735 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Health-related quality of life in patients with triple-class exposed relapsed and refractory multiple myeloma treated with idecabtagene vicleucel or standard regimens: patient-reported outcomes from the phase 3, randomised, open-label KarMMa-3 clinical trial.
Delforge M, Patel K, Eliason L, Dhanda D, Shi L, Guo S, Marshall TS, Arnulf B, Cavo M, Nooka A, Manier S, Callander N, Giralt S, Einsele H, Ailawadhi S, Popa McKiver M, Cook M, Rodríguez-Otero P. Delforge M, et al. Among authors: cook m. Lancet Haematol. 2024 Mar;11(3):e216-e227. doi: 10.1016/S2352-3026(24)00005-X. Lancet Haematol. 2024. PMID: 38423700 Clinical Trial.
Ide-cel or Standard Regimens in Relapsed and Refractory Multiple Myeloma.
Rodriguez-Otero P, Ailawadhi S, Arnulf B, Patel K, Cavo M, Nooka AK, Manier S, Callander N, Costa LJ, Vij R, Bahlis NJ, Moreau P, Solomon SR, Delforge M, Berdeja J, Truppel-Hartmann A, Yang Z, Favre-Kontula L, Wu F, Piasecki J, Cook M, Giralt S. Rodriguez-Otero P, et al. Among authors: cook m. N Engl J Med. 2023 Mar 16;388(11):1002-1014. doi: 10.1056/NEJMoa2213614. Epub 2023 Feb 10. N Engl J Med. 2023. PMID: 36762851 Clinical Trial.
Plain Language Summary of the KarMMa-3 study of ide-cel or standard of care regimens in people with relapsed or refractory multiple myeloma.
Rodriguez-Otero P, Ailawadhi S, Arnulf B, Patel K, Cavo M, Nooka AK, Manier S, Callander N, Costa LJ, Vij R, Bahlis NJ, Moreau P, Solomon SR, Delforge M, Berdeja J, Truppel-Hartmann A, Yang Z, Favre-Kontula L, Wu F, Piasecki J, Cook M, Giralt S. Rodriguez-Otero P, et al. Among authors: cook m. Future Oncol. 2024 Apr 23. doi: 10.2217/fon-2023-0954. Online ahead of print. Future Oncol. 2024. PMID: 38651976 Free article. Review.
Late-stage borreliosis and substance abuse.
Bransfield RC, Goud Gadila SK, Kursawe LJ, Dwork AJ, Rosoklija G, Horn EJ, Cook MJ, Embers ME. Bransfield RC, et al. Among authors: cook mj. Heliyon. 2024 May 11;10(10):e31159. doi: 10.1016/j.heliyon.2024.e31159. eCollection 2024 May 30. Heliyon. 2024. PMID: 38779029 Free PMC article.
Association of Professors of Gynecology and Obstetrics Preparation for Residency Knowledge Assessment scores are more closely associated with first postgraduate year Council on Resident Education in Obstetrics and Gynecology scores than United States Medical Licensing Examination Steps 1 and 2.
Morgan A, Cook M, Christman M, Scott N, Shanks A. Morgan A, et al. Among authors: cook m. AJOG Glob Rep. 2024 Apr 30;4(2):100354. doi: 10.1016/j.xagr.2024.100354. eCollection 2024 May. AJOG Glob Rep. 2024. PMID: 38774651 Free PMC article. No abstract available.
L-plastin associated syndrome of immune deficiency and haematological cytopenia (PASIC).
Hernandez RA, Hearn JI, Bhoopalan V, Hamzeh AR, Kwong K, Diamand K, Davies A, Li FJ, Padmanabhan H, Milne R, Ballard F, Spensberger D, Gardiner EE, Miraghazadeh B, Enders A, Cook MC. Hernandez RA, et al. Among authors: cook mc. J Allergy Clin Immunol. 2024 May 4:S0091-6749(24)00458-5. doi: 10.1016/j.jaci.2024.05.001. Online ahead of print. J Allergy Clin Immunol. 2024. PMID: 38710235 Free article.
2,735 results